Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Ovarian Neoplasms"" wg kryterium: Temat


Tytuł:
CT Imaging Findings in Patients with Ovarian Cancer and Acute Abdominal Symptoms: Experience at a Tertiary Cancer Center.
Autorzy:
El Homsi M; Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
Horvat N; Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
Woodlock DP; Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
Araji A; Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
Vargas HA; Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
Bates DDB; Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA. .
Pokaż więcej
Źródło:
Emergency radiology [Emerg Radiol] 2022 Dec; Vol. 29 (6), pp. 947-952. Date of Electronic Publication: 2022 Jul 09.
Typ publikacji:
Journal Article
MeSH Terms:
Peritoneal Neoplasms*/secondary
Ovarian Neoplasms*/diagnostic imaging
Ovarian Neoplasms*/complications
Intestinal Obstruction*/diagnostic imaging
Intestinal Obstruction*/etiology
Humans ; Female ; Middle Aged ; Retrospective Studies ; Ascites/complications ; Tomography, X-Ray Computed/methods
Czasopismo naukowe
Tytuł:
Evaluation of a mainstream genetic testing program for women with ovarian or breast cancer.
Autorzy:
Ip E; Department of Cancer Genetics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.; Department of Cancer Genetics, Liverpool Hospital, Liverpool, New South Wales, Australia.
Young AL; Faculty of Medicine and Health, University of Sydney, Camperdown, New South Wales, Australia.; Sydney Catalyst Translational Research Centre, University of Sydney, Camperdown, New South Wales, Australia.
Scheinberg T; Faculty of Medicine and Health, University of Sydney, Camperdown, New South Wales, Australia.; Medical Oncology, Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia.; Advanced Prostate Cancer Group, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
Harrison M; Department of Cancer Genetics, Liverpool Hospital, Liverpool, New South Wales, Australia.; Medical Oncology, Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia.
Beale P; Sydney Catalyst Translational Research Centre, University of Sydney, Camperdown, New South Wales, Australia.; Medical Oncology, Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia.; Medical Oncology, Concord Repatriation General Hospital, Concord, New South Wales, Australia.
Goodwin A; Department of Cancer Genetics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.; Faculty of Medicine and Health, University of Sydney, Camperdown, New South Wales, Australia.; Medical Oncology, Concord Repatriation General Hospital, Concord, New South Wales, Australia.
Pokaż więcej
Źródło:
Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2022 Oct; Vol. 18 (5), pp. e414-e419. Date of Electronic Publication: 2022 Jan 30.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/diagnosis
Breast Neoplasms*/genetics
Ovarian Neoplasms*/diagnosis
Ovarian Neoplasms*/genetics
Carcinoma, Ovarian Epithelial/genetics ; Female ; Genes, BRCA1 ; Genes, BRCA2 ; Genetic Predisposition to Disease ; Genetic Testing/methods ; Humans ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Deficiency of tumor-expressed B7-H3 augments anti-tumor efficacy of anti-PD-L1 monotherapy rather than the combined chemoimmunotherapy in ovarian cancer.
Autorzy:
Huang M; National Key Laboratory of Medical Immunology & Institute of Immunology, Second Military Medical University, Shanghai 200433, China.
Luo J; National Key Laboratory of Medical Immunology & Institute of Immunology, Second Military Medical University, Shanghai 200433, China.
Ji X; Department of Ophthalmology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
Hu M; Department of Orthopedics, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China.
Xue Y; National Key Laboratory of Medical Immunology & Institute of Immunology, Second Military Medical University, Shanghai 200433, China.
Liu Q; National Key Laboratory of Medical Immunology & Institute of Immunology, Second Military Medical University, Shanghai 200433, China. Electronic address: .
Pokaż więcej
Źródło:
Pharmacological research [Pharmacol Res] 2022 Dec; Vol. 186, pp. 106512. Date of Electronic Publication: 2022 Oct 19.
Typ publikacji:
Journal Article
MeSH Terms:
B7 Antigens*/metabolism
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/pathology
Humans ; Mice ; Female ; Animals ; Immunotherapy ; Tumor Microenvironment ; Paclitaxel/pharmacology ; Paclitaxel/therapeutic use
Czasopismo naukowe
Tytuł:
Nanotechnological approaches for diagnosis and treatment of ovarian cancer: a review of recent trends.
Autorzy:
Ding H; Department of Gynecology, Shaoxing Maternity and Child Health Care Hospital, Shaoxing, China.; Obstetrics and Gynecology Hospital, Shaoxing University, Shaoxing, China.
Zhang J; Department of Gynecology, Shaoxing Maternity and Child Health Care Hospital, Shaoxing, China.; Obstetrics and Gynecology Hospital, Shaoxing University, Shaoxing, China.
Zhang F; Department of Gynecology, Shaoxing Maternity and Child Health Care Hospital, Shaoxing, China.; Obstetrics and Gynecology Hospital, Shaoxing University, Shaoxing, China.
Xu Y; Intensive Care Unit, Zhoushan Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Zhoushan, China.
Liang W; Medical Research Center, Zhoushan Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Zhoushan, China.
Yu Y; Medical Research Center, Zhoushan Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Zhoushan, China.
Pokaż więcej
Źródło:
Drug delivery [Drug Deliv] 2022 Dec; Vol. 29 (1), pp. 3218-3232.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Dendrimers*
Nanocapsules*
Nanoparticles*
Ovarian Neoplasms*/diagnosis
Ovarian Neoplasms*/drug therapy
Female ; Humans ; Cadherins/therapeutic use ; Carcinoma, Ovarian Epithelial/drug therapy ; Drug Delivery Systems ; Ligands ; Liposomes ; Nanotechnology
Czasopismo naukowe
Tytuł:
Bilateral ovarian metastasis after laparoscopic right hemicolectomy for signet-ring cell carcinoma.
Autorzy:
Wu CY; Department of Gastrointestinal Surgery, the Second Affiliated Hospital of Fujian Medical University, No. 950 Donghai Street, Fengze Distrct, Quanzhou, 362000, Fujian Province, China.
Ye K; Department of Gastrointestinal Surgery, the Second Affiliated Hospital of Fujian Medical University, No. 950 Donghai Street, Fengze Distrct, Quanzhou, 362000, Fujian Province, China. Electronic address: .
Pokaż więcej
Źródło:
Asian journal of surgery [Asian J Surg] 2022 Dec; Vol. 45 (12), pp. 2903-2904. Date of Electronic Publication: 2022 Jun 29.
Typ publikacji:
Letter
MeSH Terms:
Carcinoma, Signet Ring Cell*/surgery
Carcinoma, Signet Ring Cell*/pathology
Ovarian Neoplasms*/surgery
Ovarian Neoplasms*/pathology
Laparoscopy*
Humans ; Female ; Colectomy
Opinia redakcyjna
Tytuł:
Isolation of Potential Compound from the Leaves of Elytraria acaulis and Evaluating Its Therapeutic Properties Using In Vitro Studies Against Ovarian Cancer.
Autorzy:
Priya P; PG & Research Department of Zoology, Pachaiyappa's College, Chennai, 600 030, Tamil Nadu, India. .
Anbarasu M; PG & Research Department of Chemistry, Pachaiyappa's College, Chennai, 600 030, Tamil Nadu, India.
Christina VS; Department of Biotechnology, Faculty of Biomedical Sciences and Technology, SRI RAMACHANDRA Institute of Higher Education and Research (SRIHER), Deemed to Be University (DU), Chennai, 600 116, Tamil Nadu, India.
Majeed SA; PG and Research Department of Zoology, C. Abdul Hakeem College (Autonomous), Melvisharam, 632 509, Tamil Nadu, India.
Sivamurugan V; PG & Research Department of Chemistry, Pachaiyappa's College, Chennai, 600 030, Tamil Nadu, India. .
Sundaram RL; Central Research Facility (CRF), SRI RAMACHANDRA Institute of Higher Education and Research (SRIHER), Deemed to Be University (DU), Chennai, 600 116, Tamil Nadu, India.
Pokaż więcej
Źródło:
Applied biochemistry and biotechnology [Appl Biochem Biotechnol] 2022 Dec; Vol. 194 (12), pp. 5607-5626. Date of Electronic Publication: 2022 Jul 07.
Typ publikacji:
Journal Article
MeSH Terms:
Apoptosis*
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/metabolism
Humans ; Female ; Cell Proliferation ; Plant Leaves/metabolism ; Cell Survival ; Plant Extracts/chemistry
Czasopismo naukowe
Tytuł:
Comments on "Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial".
Autorzy:
Bhatt A; Department of Surgical Oncology, Zydus Hospital, Ahmedabad, India.
Bhandoria G; Department of Gynecologic Oncology, Command Hospital, Kolkata, India.
Kepenekian V; Department of Surgical Oncology, Centre Hospitalier Lyon Sud, Lyon, France.
Bakrin N; Department of Surgical Oncology, Centre Hospitalier Lyon Sud, Lyon, France.
Glehen O; Department of Surgical Oncology, Centre Hospitalier Lyon Sud, Lyon, France.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2022 Dec 01; Vol. 151 (11), pp. 2055-2056. Date of Electronic Publication: 2022 Aug 05.
Typ publikacji:
Clinical Trial, Phase III; Letter; Comment
MeSH Terms:
Hyperthermia, Induced*/methods
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/therapy
Carcinoma, Ovarian Epithelial/drug therapy ; Cytoreduction Surgical Procedures/methods ; Female ; Genomics ; Humans ; Hyperthermic Intraperitoneal Chemotherapy
Raport
Tytuł:
A machine learning approach applied to gynecological ultrasound to predict progression-free survival in ovarian cancer patients.
Autorzy:
Arezzo F; Department of Biomedical Sciences and Human Oncology, Obstetrics and Gynecology Unit, University of Bari 'Aldo Moro', Piazza Giulio Cesare 11, 70124, Bari, Italy. .
Cormio G; Department of Biomedical Sciences and Human Oncology, Obstetrics and Gynecology Unit, University of Bari 'Aldo Moro', Piazza Giulio Cesare 11, 70124, Bari, Italy.
La Forgia D; Department of Breast Radiology, Giovanni Paolo II I.R.C.C.S. Cancer Institute, via Orazio Flacco 65, 70124, Bari, Italy.
Santarsiero CM; Department of Biomedical Sciences and Human Oncology, Obstetrics and Gynecology Unit, University of Bari 'Aldo Moro', Piazza Giulio Cesare 11, 70124, Bari, Italy.
Mongelli M; Department of Biomedical Sciences and Human Oncology, Obstetrics and Gynecology Unit, University of Bari 'Aldo Moro', Piazza Giulio Cesare 11, 70124, Bari, Italy.
Lombardi C; Department of Biomedical Sciences and Human Oncology, Obstetrics and Gynecology Unit, University of Bari 'Aldo Moro', Piazza Giulio Cesare 11, 70124, Bari, Italy.
Cazzato G; Department of Emergency and Organ Transplantation, Pathology Section, University of Bari 'Aldo Moro', Piazza Giulio Cesare 11, 70124, Bari, Italy.
Cicinelli E; Department of Biomedical Sciences and Human Oncology, Obstetrics and Gynecology Unit, University of Bari 'Aldo Moro', Piazza Giulio Cesare 11, 70124, Bari, Italy.
Loizzi V; Interdisciplinar Department of Medicine, Obstetrics and Gynecology Unit, University of Bari 'Aldo Moro', Piazza Giulio Cesare 11, 70124, Bari, Italy.
Pokaż więcej
Źródło:
Archives of gynecology and obstetrics [Arch Gynecol Obstet] 2022 Dec; Vol. 306 (6), pp. 2143-2154. Date of Electronic Publication: 2022 May 09.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Machine Learning*
Ovarian Neoplasms*/diagnostic imaging
Ovarian Neoplasms*/surgery
Ovarian Neoplasms*/pathology
Humans ; Female ; Carcinoma, Ovarian Epithelial/diagnostic imaging ; Progression-Free Survival ; Ultrasonography
Czasopismo naukowe
Tytuł:
Cystic Granulosa Cell Tumors of the Ovary: An Analysis of 80 Cases of an Often Diagnostically Challenging Entity.
Autorzy:
Boyraz B; From the James Homer Wright Pathology Laboratories, Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (Boyraz, Watkins, Oliva, Young).
Watkins JC; From the James Homer Wright Pathology Laboratories, Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (Boyraz, Watkins, Oliva, Young).
Soubeyran I; The Pathology Department, Institut Bergonié, Bordeaux, France (Soubeyran, Bonhomme, Croce).
Bonhomme B; The Pathology Department, Institut Bergonié, Bordeaux, France (Soubeyran, Bonhomme, Croce).
Croce S; The Pathology Department, Institut Bergonié, Bordeaux, France (Soubeyran, Bonhomme, Croce).
Oliva E; From the James Homer Wright Pathology Laboratories, Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (Boyraz, Watkins, Oliva, Young).
Young RH; From the James Homer Wright Pathology Laboratories, Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (Boyraz, Watkins, Oliva, Young).
Pokaż więcej
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2022 Dec 01; Vol. 146 (12), pp. 1450-1459.
Typ publikacji:
Journal Article
MeSH Terms:
Granulosa Cell Tumor*/diagnosis
Granulosa Cell Tumor*/genetics
Ovarian Neoplasms*/diagnosis
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/metabolism
Cysts*
Adult ; Female ; Humans ; Child, Preschool ; Child ; Adolescent ; Young Adult ; Middle Aged ; Aged ; Aged, 80 and over ; Mutation
Czasopismo naukowe
Tytuł:
Olaparib maintenance monotherapy in Chinese patients with platinum-sensitive relapsed ovarian cancer: China cohort from the phase III SOLO2 trial.
Autorzy:
Liu J; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Yin R; Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu, China.; Key Laboratory of Obstetrics & Gynecologic and Pediatric Diseases and Birth Defects of the Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China.
Wu L; Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Zhu J; Department of Gynecologic Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.
Lou G; Department of Gynecology Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
Wu X; Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Zhou Q; Chongqing Cancer Hospital, Chongqing, China.
Gao Y; Beijing Cancer Hospital, Beijing, China.
Kong B; Qilu Hospital of Shandong University, Jinan, China.
Lu X; Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
Wang J; Hunan Cancer Hospital, Changsha, China.
Chen Y; The First Affiliated Hospital of Soochow University, Suzhou, China.
Cheng Y; Jilin Cancer Hospital, Changchun, China.
Wang Y; No. 1 Affiliated Hospital of Medical School, Xi'an Jiaotong University, Xi'an, China.
Lu W; Women's Hospital School of Medicine, Zhejiang University, Hangzhou, China.
Li W; Oncology Center, The First Hospital of Jilin University, Changchun, China.
Ma X; AstraZeneca, Shanghai, China.
Hsu K; Celgene, San Diego, California, USA.
Pokaż więcej
Źródło:
Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2022 Dec; Vol. 18 (6), pp. 714-722. Date of Electronic Publication: 2022 Mar 31.
Typ publikacji:
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
MeSH Terms:
Antineoplastic Agents*/therapeutic use
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/genetics
Female ; Humans ; Carcinoma, Ovarian Epithelial/drug therapy ; Carcinoma, Ovarian Epithelial/genetics ; Maintenance Chemotherapy ; Neoplasm Recurrence, Local/drug therapy ; Phthalazines/adverse effects
Czasopismo naukowe
Tytuł:
Failure of Operative Therapy after Ovarian-Sparing Surgery for Pediatric Benign Ovarian Neoplasms: A Retrospective Review.
Autorzy:
Knaus ME; Center for Surgical Outcomes Research, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, Ohio; Division of Pediatric Surgery, Department of Surgery, The Ohio State University College of Medicine, Nationwide Children's Hospital, Columbus, Ohio.
Onwuka AJ; Center for Surgical Outcomes Research, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, Ohio.
Abouelseoud NM; Division of Pediatric and Adolescent Gynecology, Department of Obstetrics and Gynecology, University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Breech LL; Division of Pediatric and Adolescent Gynecology, Department of Obstetrics and Gynecology, University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Brito KS; University of Chicago Pritzker School of Medicine, Chicago, Illinois.
Dekonenko C; Department of Pediatric Surgery, Children's Mercy Hospital, Kansas City, Missouri.
Hertweck SP; Division of Pediatric and Adolescent Gynecology, Norton Children's Gynecology, Louisville, Kentucky.
Hong HY; Department of Obstetrics and Gynecology, University of California, Irvine, Irvine, California.
Lawrence AE; Center for Surgical Outcomes Research, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, Ohio; Division of Pediatric Surgery, Department of Surgery, The Ohio State University College of Medicine, Nationwide Children's Hospital, Columbus, Ohio.
Menon S; Department of Obstetrics and Gynecology, Medical College of Wisconsin, Children's Wisconsin, Milwaukee, Wisconsin.
Merritt DF; Division of Pediatric and Adolescent Gynecology, Department of Obstetrics and Gynecology, Washington University School of Medicine in St. Louis, St. Louis Children's Hospital, St. Louis, Missouri.
Schikler AG; University of Louisville School of Medicine, Louisville, Kentucky.
Senapati N; Department of Obstetrics and Gynecology, University of Michigan Medical School, Ann Arbor, Michigan.
Smith YR; Department of Obstetrics and Gynecology, University of Michigan Medical School, Ann Arbor, Michigan.
Strickland JL; Division of Pediatric and Adolescent Gynecology, Department of Obstetrics and Gynecology, University of Missouri-Kansas City School of Medicine, Children's Mercy Hospital, Kansas City, Missouri.
Truehart AI; Section of Family Planning, Department of Obstetrics and Gynecology, University of Chicago Medicine, Chicago, Illinois.
Minneci PC; Center for Surgical Outcomes Research, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, Ohio; Division of Pediatric Surgery, Department of Surgery, The Ohio State University College of Medicine, Nationwide Children's Hospital, Columbus, Ohio.
Hewitt GD; Division of Pediatric and Adolescent Gynecology, Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Nationwide Children's Hospital, Columbus, Ohio. Electronic address: .
Pokaż więcej
Źródło:
Journal of pediatric and adolescent gynecology [J Pediatr Adolesc Gynecol] 2022 Dec; Vol. 35 (6), pp. 702-706. Date of Electronic Publication: 2022 Aug 26.
Typ publikacji:
Journal Article
MeSH Terms:
Teratoma*/surgery
Ovarian Neoplasms*/surgery
Ovarian Neoplasms*/pathology
Laparoscopy*/methods
Child ; Humans ; Female ; Retrospective Studies ; Laparotomy
Czasopismo naukowe
Tytuł:
Short divalent ethacrynic amides as pro-inhibitors of glutathione S -transferase isozyme Mu and potent sensitisers of cisplatin-resistant ovarian cancers.
Autorzy:
Xu B; Key Laboratory of Clinical Laboratory Diagnostics of the Education Ministry, College of Laboratory Medicine, Chongqing Medical University, Chongqing, China.; Department of Pharmacy, University-Town Hospital of Chongqing Medical University, Chongqing, China.
Tong T; Key Laboratory of Clinical Laboratory Diagnostics of the Education Ministry, College of Laboratory Medicine, Chongqing Medical University, Chongqing, China.
Wang X; Key Laboratory of Clinical Laboratory Diagnostics of the Education Ministry, College of Laboratory Medicine, Chongqing Medical University, Chongqing, China.
Liu F; Key Laboratory of Clinical Laboratory Diagnostics of the Education Ministry, College of Laboratory Medicine, Chongqing Medical University, Chongqing, China.
Zhang X; Key Laboratory of Clinical Laboratory Diagnostics of the Education Ministry, College of Laboratory Medicine, Chongqing Medical University, Chongqing, China.
Hu X; Key Laboratory of Clinical Laboratory Diagnostics of the Education Ministry, College of Laboratory Medicine, Chongqing Medical University, Chongqing, China.
Li X; Key Laboratory of Clinical Laboratory Diagnostics of the Education Ministry, College of Laboratory Medicine, Chongqing Medical University, Chongqing, China.
Yang X; Key Laboratory of Clinical Laboratory Diagnostics of the Education Ministry, College of Laboratory Medicine, Chongqing Medical University, Chongqing, China.
Liao F; Key Laboratory of Clinical Laboratory Diagnostics of the Education Ministry, College of Laboratory Medicine, Chongqing Medical University, Chongqing, China.
Pokaż więcej
Źródło:
Journal of enzyme inhibition and medicinal chemistry [J Enzyme Inhib Med Chem] 2022 Dec; Vol. 37 (1), pp. 728-742.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Agents/*pharmacology
Cisplatin/*pharmacology
Ethacrynic Acid/*pharmacology
Ethylenediamines/*pharmacology
Glutathione Transferase/*antagonists & inhibitors
Ovarian Neoplasms/*drug therapy
Putrescine/*pharmacology
Animals ; Antineoplastic Agents/chemistry ; Cell Proliferation/drug effects ; Cisplatin/chemistry ; Dose-Response Relationship, Drug ; Drug Resistance, Neoplasm/drug effects ; Drug Screening Assays, Antitumor ; Ethacrynic Acid/chemistry ; Ethylenediamines/chemistry ; Female ; Glutathione Transferase/metabolism ; Humans ; Isoenzymes/antagonists & inhibitors ; Isoenzymes/metabolism ; Mice ; Mice, Nude ; Molecular Structure ; Neoplasms, Experimental/drug therapy ; Neoplasms, Experimental/metabolism ; Neoplasms, Experimental/pathology ; Ovarian Neoplasms/metabolism ; Ovarian Neoplasms/pathology ; Putrescine/chemistry ; Structure-Activity Relationship
Czasopismo naukowe
Tytuł:
Long-term surgical outcomes in pediatric ovarian neoplasms: 20-year single-center experience.
Autorzy:
Toker Kurtmen B; Department of Pediatric Surgery, Ege University Faculty of Medicine, Bornova, 35100, İzmir, Turkey.
Dokumcu Z; Department of Pediatric Surgery, Ege University Faculty of Medicine, Bornova, 35100, İzmir, Turkey.
Divarci E; Department of Pediatric Surgery, Ege University Faculty of Medicine, Bornova, 35100, İzmir, Turkey.
Ergun O; Department of Pediatric Surgery, Ege University Faculty of Medicine, Bornova, 35100, İzmir, Turkey.
Ozok G; Department of Pediatric Surgery, Ege University Faculty of Medicine, Bornova, 35100, İzmir, Turkey.
Celik A; Department of Pediatric Surgery, Ege University Faculty of Medicine, Bornova, 35100, İzmir, Turkey. .
Pokaż więcej
Źródło:
Pediatric surgery international [Pediatr Surg Int] 2022 Dec; Vol. 38 (12), pp. 2035-2044. Date of Electronic Publication: 2022 Sep 28.
Typ publikacji:
Journal Article
MeSH Terms:
Ovarian Neoplasms*/surgery
Ovarian Neoplasms*/pathology
Child ; Humans ; Female ; Adolescent ; Retrospective Studies ; Ovariectomy/methods ; Treatment Outcome ; Neoplasm Recurrence, Local/epidemiology ; Neoplasm Recurrence, Local/surgery ; Neoplasm Staging
Czasopismo naukowe
Tytuł:
Treatment delay and treatment pattern modifications among epithelial ovarian cancer patients during the COVID-19 pandemic: A retrospective cohort study.
Autorzy:
Moterani VC; Department of Gynaecology and Obstetrics, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.; Department of Obstetrics and Gynaecology, Marilia Medical School, Marilia, Brazil.
Moterani NJW Jr; Department of Gynaecology and Obstetrics, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.; Department of Obstetrics and Gynaecology, Marilia Medical School, Marilia, Brazil.
Candido Dos Reis FJ; Department of Gynaecology and Obstetrics, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Pokaż więcej
Źródło:
Journal of surgical oncology [J Surg Oncol] 2022 Dec; Vol. 126 (7), pp. 1155-1161. Date of Electronic Publication: 2022 Aug 05.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
Ovarian Neoplasms*/therapy
Ovarian Neoplasms*/drug therapy
Humans ; Female ; Pandemics ; Carcinoma, Ovarian Epithelial/therapy ; Retrospective Studies ; Time-to-Treatment ; Brazil/epidemiology ; Cohort Studies
Czasopismo naukowe
Tytuł:
PUMA overexpression dissociates thioredoxin from ASK1 to activate the JNK/BCL-2/BCL-XL pathway augmenting apoptosis in ovarian cancer.
Autorzy:
Chen Y; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Sichuan University, 17 People's South Road, Chengdu 610041, China.
Li N; Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Yang J; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Sichuan University, 17 People's South Road, Chengdu 610041, China.
Li K; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Sichuan University, 17 People's South Road, Chengdu 610041, China.
Tang M; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Sichuan University, 17 People's South Road, Chengdu 610041, China.
Zhao X; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Sichuan University, 17 People's South Road, Chengdu 610041, China.
Guo W; Department of Abdominal Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, Sichuan Province, China.
Tong A; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Sichuan University, 17 People's South Road, Chengdu 610041, China.
Nie C; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Sichuan University, 17 People's South Road, Chengdu 610041, China.
Peng Y; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Sichuan University, 17 People's South Road, Chengdu 610041, China.
Yuan Z; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Sichuan University, 17 People's South Road, Chengdu 610041, China. Electronic address: .
Pokaż więcej
Źródło:
Biochimica et biophysica acta. Molecular basis of disease [Biochim Biophys Acta Mol Basis Dis] 2022 Dec 01; Vol. 1868 (12), pp. 166553. Date of Electronic Publication: 2022 Sep 17.
Typ publikacji:
Journal Article
MeSH Terms:
Apoptosis Regulatory Proteins*/genetics
Apoptosis Regulatory Proteins*/metabolism
Cisplatin*/pharmacology
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/metabolism
Proto-Oncogene Proteins*/genetics
Proto-Oncogene Proteins*/metabolism
Apoptosis ; Female ; Humans ; Hydrogen Peroxide/pharmacology ; Paclitaxel/pharmacology ; Proto-Oncogene Proteins c-bcl-2/genetics ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Reactive Oxygen Species/metabolism ; Thioredoxins/genetics ; Thioredoxins/metabolism ; bcl-2-Associated X Protein/genetics
Czasopismo naukowe
Tytuł:
The worsening impact of programmed cell death ligand 1 in ovarian clear cell carcinomas.
Autorzy:
Matsuura H; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan.
Miyamoto M; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan. .
Hada T; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan.
Ishibashi H; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan.
Iwahashi H; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan.
Kakimoto S; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan.
Suzuki R; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan.
Ito T; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan.
Suminokura J; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan.
Tsuda H; Department of Basic Pathology, National Defense Medical College Hospital, Tokorozawa, Saitama, 359-8513, Japan.
Takano M; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan.
Pokaż więcej
Źródło:
Archives of gynecology and obstetrics [Arch Gynecol Obstet] 2022 Dec; Vol. 306 (6), pp. 2133-2142. Date of Electronic Publication: 2022 May 04.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma, Clear Cell*/metabolism
Adenocarcinoma, Clear Cell*/surgery
B7-H1 Antigen*/metabolism
Ovarian Neoplasms*/metabolism
Ovarian Neoplasms*/surgery
Female ; Humans ; Apoptosis ; Biomarkers, Tumor/metabolism ; Ligands ; Lymphocytes, Tumor-Infiltrating/metabolism ; Prognosis
Czasopismo naukowe
Tytuł:
Diagnostic and prognostic role of TFF3, Romo-1, NF-кB and SFRP4 as biomarkers for endometrial and ovarian cancers: a prospective observational translational study.
Autorzy:
Turan H; Department of Gynecologic Oncology, Health Science University, Cam Sakura Training and Research Hospital, Istanbul, Turkey.
Vitale SG; Obstetrics and Gynecology Unit, Department of General Surgery and Medical Surgical Specialties, University of Catania, Via Santa Sofia 78, 95123, Catania, Italy. .
Kahramanoglu I; Department of Gynecologic Oncology, Emsey Hospital, Istanbul, Turkey.
Della Corte L; Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples, Naples, Italy.
Giampaolino P; Department of Public Health, University of Naples Federico II, Via Sergio Pansini, Naples, Italy.
Azemi A; Department of Biochemistry, School of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Durmus S; Department of Biochemistry, School of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Sal V; Department of Obstetrics and Gynecology, Memorial Bahcelievler Hospital, Istanbul, Turkey.
Tokgozoglu N; Department of Gynecologic Oncology, Okmeydanı Training and Research Hospital, Istanbul, Turkey.
Bese T; Department of Gynecologic Oncology, School of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Arvas M; Department of Gynecologic Oncology, American Hospital, Istanbul, Turkey.
Demirkiran F; Department of Gynecologic Oncology, School of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Gelisgen R; Department of Biochemistry, School of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Ilvan S; Department of Pathology, School of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Uzun H; Department of Biochemistry, School of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Pokaż więcej
Źródło:
Archives of gynecology and obstetrics [Arch Gynecol Obstet] 2022 Dec; Vol. 306 (6), pp. 2105-2114. Date of Electronic Publication: 2022 Apr 24.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
NF-kappa B*/metabolism
Ovarian Neoplasms*/diagnosis
Ovarian Neoplasms*/metabolism
Humans ; Female ; Prospective Studies ; Prognosis ; Biomarkers ; Trefoil Factor-3 ; Proto-Oncogene Proteins ; Membrane Proteins ; Mitochondrial Proteins
Czasopismo naukowe
Tytuł:
CircCERS6 Suppresses the Development of Epithelial Ovarian Cancer Through Mediating miR-630/RASSF8.
Autorzy:
Li X; Clinical Laboratory, Urumqi Maternal and Child Health Care Hospital, Urumqi, Xinjiang, China.
Jiang X; Clinical Laboratory, Urumqi Maternal and Child Health Care Hospital, Urumqi, Xinjiang, China.
Lu J; Department of Gynecology, Urumqi Maternal and Child Health Care Hospital, Urumqi, Xinjiang, China.
Lin Y; Clinical Laboratory, Urumqi Maternal and Child Health Care Hospital, Urumqi, Xinjiang, China.
Jiang L; Clinical Laboratory, Urumqi Maternal and Child Health Care Hospital, Urumqi, Xinjiang, China.
Li Y; Clinical Laboratory, Urumqi Maternal and Child Health Care Hospital, Urumqi, Xinjiang, China.
Wan F; Clinical Laboratory, Urumqi Maternal and Child Health Care Hospital, Urumqi, Xinjiang, China.
Wang C; Clinical Laboratory Center, People's Hospital of Xinjiang Uygur Autonomous Region, Tianshan District, No. 91 Tianchi Road, Urumqi, 830001, Xinjiang, China. .
Pokaż więcej
Źródło:
Biochemical genetics [Biochem Genet] 2022 Dec; Vol. 60 (6), pp. 2611-2629. Date of Electronic Publication: 2022 Jun 08.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Ovarian Epithelial*/genetics
Carcinoma, Ovarian Epithelial*/metabolism
Carcinoma, Ovarian Epithelial*/pathology
MicroRNAs*/genetics
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/metabolism
Ovarian Neoplasms*/pathology
Tumor Suppressor Proteins*/genetics
RNA, Circular*/genetics
Animals ; Female ; Humans ; Mice ; Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation/genetics ; Gene Expression Regulation, Neoplastic
Czasopismo naukowe
Tytuł:
Piezo1 activation facilitates ovarian cancer metastasis via Hippo/YAP signaling axis.
Autorzy:
Xiong Y; Department of Pathology, North China University of Science and Technology Affiliated Hospital, Tangshan, Hebei China.
Dong L; Department of Pathology, North China University of Science and Technology Affiliated Hospital, Tangshan, Hebei China.
Bai Y; College of Life Science, North China University of Science and Technology, Tangshan, Hebei China.
Tang H; Department of Pathology, North China University of Science and Technology Affiliated Hospital, Tangshan, Hebei China.
Li S; Department of Pathology, North China University of Science and Technology Affiliated Hospital, Tangshan, Hebei China.
Luo D; Department of Pathology, North China University of Science and Technology Affiliated Hospital, Tangshan, Hebei China.
Liu F; Department of Pathology, North China University of Science and Technology Affiliated Hospital, Tangshan, Hebei China.
Bai J; Department of Pathology, North China University of Science and Technology Affiliated Hospital, Tangshan, Hebei China.
Yang S; Department of Pathology, North China University of Science and Technology Affiliated Hospital, Tangshan, Hebei China.
Song X; Department of Pathology, North China University of Science and Technology Affiliated Hospital, Tangshan, Hebei China.
Pokaż więcej
Źródło:
Channels (Austin, Tex.) [Channels (Austin)] 2022 Dec; Vol. 16 (1), pp. 159-166.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/metabolism
Ovarian Neoplasms*/pathology
Animals ; Cell Line, Tumor ; Cell Movement ; Cell Proliferation ; Epithelial-Mesenchymal Transition ; Female ; Humans ; Ion Channels ; Mice ; Mice, Nude
Czasopismo naukowe
Tytuł:
Reply to: Comments on "Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial".
Autorzy:
Koole SN; Department of Gynecology, The Netherlands Cancer Institute, Center of Gynecologic Oncology Amsterdam, Amsterdam, The Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Schouten PC; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
van Driel WJ; Department of Gynecology, The Netherlands Cancer Institute, Center of Gynecologic Oncology Amsterdam, Amsterdam, The Netherlands.
Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Linn SC; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2022 Dec 01; Vol. 151 (11), pp. 2057-2058. Date of Electronic Publication: 2022 Aug 05.
Typ publikacji:
Clinical Trial, Phase II; Letter; Comment
MeSH Terms:
Hyperthermia, Induced*/methods
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/therapy
Carcinoma, Ovarian Epithelial/drug therapy ; Cytoreduction Surgical Procedures/methods ; Female ; Genomics ; Humans ; Hyperthermic Intraperitoneal Chemotherapy
Raport

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz